KEMP BAILEY CEASE
Medical Practice in Ann Arbor, MI
License number
Michigan 4301045245
Issued Date
Sep 16, 1982
Expiration Date
Jan 31, 2019
Category
Medicine
Type
Medical Doctor
Address
Address
Ann Arbor, MI 48109
Personal information
See more information about KEMP BAILEY CEASE at radaris.comName
Address
Phone
2260 Georgetown Blvd, Ann Arbor, MI 48105
Ann Arbor, MI
2260 Georgetown Blvd, Ann Arbor, MI 48105
2260 Yorktown Dr, Ann Arbor, MI 48105
Professional information
See more information about KEMP BAILEY CEASE at trustoria.com
Kemp B Cease, Ann Arbor MI
Kemp B Cease, Ann Arbor MI
Specialties:
Oncologist
Address:
1500 E Medical Center Dr, Ann Arbor, MI 48109
Education:
University of North Carolina, School of Medicine - Doctor of Medicine
National Institutes of Health-Clinical Center - Fellowship - Research
National Institutes of Health-Clinical Center - Fellowship - Research
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine, American Board of Internal Medicine Sub-certificate in Oncology (Internal Medicine)
Kemp Cease, Ann Arbor MI
Kemp Cease, Ann Arbor MI
Work:
Ann Arbor Veterans Affairs Medical Center
2215 Fuller Rd, Ann Arbor, MI 48105
2215 Fuller Rd, Ann Arbor, MI 48105
Dr. Kemp B Cease, Ann Arbor MI - MD (Doctor of Medicine)
Dr. Kemp B Cease, Ann Arbor MI - MD (Doctor of Medicine)
Specialties:
Oncology, Medical Oncology
Address:
VA Ann Arbor Medical Center
2215 Fuller Rd, Ann Arbor 48105
(734) 769-7100 (Phone)
2215 Fuller Rd, Ann Arbor 48105
(734) 769-7100 (Phone)
Certifications:
Internal Medicine, 1984, Medical Oncology, 2011
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
VA Ann Arbor Medical Center
2215 Fuller Rd, Ann Arbor 48105
ProMedica Herrick Hospital
500 East Pottawatamie St, Tecumseh 49286
2215 Fuller Rd, Ann Arbor 48105
ProMedica Herrick Hospital
500 East Pottawatamie St, Tecumseh 49286
Education:
Medical School
University Of North Carolina, Chapel Hill, School Of Medicine
Graduated: 1981
University Of Michigan
Graduated: 1982
Graduated: 1984
National Institute Of Health
Graduated: 1987
University Of North Carolina, Chapel Hill, School Of Medicine
Graduated: 1981
University Of Michigan
Graduated: 1982
Graduated: 1984
National Institute Of Health
Graduated: 1987
Vectors For Cloning And Modification Of Dna Fragments
Vectors For Cloning And Modification Of Dna Fragments
US Patent:
5827704, Oct 27, 1998
Filed:
Feb 28, 1996
Appl. No.:
8/608437
Inventors:
Kemp B. Cease - Ann Arbor MI
Cortland J. Lohff - Madison WI
Cortland J. Lohff - Madison WI
Assignee:
The Regents Of The University Of Michigan - Ann Arbor MI
International Classification:
C12N 1500, C12N 1511
US Classification:
4351723
Abstract:
Plasmid vectors are provided which enable for the modification of double-stranded DNA which has blunt or one-base 3' overhanging termini, to include any desired four-base 5' overhang sequence, in the reading frame of choice. These vectors enable the cloning of blunt double-stranded DNA sequences or double-stranded DNA sequences having a one-base 3' overhang into a unique restriction site by blunt-end ligation or by one-base 3' overhang cohesive cloning such as T-cloning. The vectors may be amplified and subsequently excised, thereby producing modified fragments free of vector sequences.
Epitope-Targeted Anthrax Vaccine
Epitope-Targeted Anthrax Vaccine
US Patent:
2011025, Oct 20, 2011
Filed:
Oct 14, 2009
Appl. No.:
13/124167
Inventors:
Kemp B. Cease - Ann Arbor MI, US
Jon Oscherwitz - Ann Arbor MI, US
Jon Oscherwitz - Ann Arbor MI, US
Assignee:
THE REGENTS OF THE UNIVERSITY OF MICHIGAN - Ann Arbor MI
International Classification:
A61K 39/07, A61P 37/04, A61P 31/04, C07K 19/00
US Classification:
42419711, 530300, 530350, 530317
Abstract:
Anthrax vaccine compositions comprise a segment of a PA toxin protein that stimulates a B cell immune response specific for a defined epitope on the protective antigen of , a pharmaceutical excipient and optionally, one or more other protein segments comprising epitopes that augment the B cell response by stimulating a T cell immune response. The pharmaceutical compositions are useful for vaccinating individuals so as to confer protection from disease caused by including anthrax disease resulting from anthrax spore inhalation.